EGFR mutations are found in approximately 50% of cases recorded in Asian populations, whereas KRAS mutations predominate in Caucasian lung cancer populations with a frequency of 30–35% (Reck et al., 2021). The gene discussed is KRAS; the disease is lung carcinoma.